PubRank

Jeremy Hoog

Author PubWeight™ 42.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010 19.68
2 Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012 8.03
3 Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep 2013 3.85
4 Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol 2011 2.71
5 Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003 2.15
6 PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer. Cancer Res 2009 2.01
7 Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Res Treat 2010 1.60
8 Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest 2012 1.49
9 ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 2008 1.33
10 Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J Clin Oncol 2010 1.17
11 Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun 2017 0.75